In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect

被引：34

作者：

Gunderson, SM

Hoffman, H

Ernst, EJ

Pfaller, MA

Klepser, ME

机构：

[1] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA

[2] Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2000年 / 44卷 / 10期

关键词：

D O I：

10.1128/AAC.44.10.2887-2890.2000

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Four Candida albicans isolates and six non-albicans Candida isolates were evaluated by time-kill methods to characterize the relationship between nystatin concentrations, the rate and extent of fungicidal activity, and the postantifungal effect (PAFE). Against Candida species, nystatin exhibits concentration-dependent fungicidal activity and a pronounced PAFE.

引用

收藏

页码：2887 / 2890

页数：4

相关论文

共 12 条

[1]

Alvarez Alvarez M E, 1998, Rev Esp Quimioter, V11, P295

[2]

Ellepola ANB, 1999, J ORAL PATHOL MED, V28, P112, DOI 10.1111/j.1600-0714.1999.tb02007.x

[3] In vitro interaction of fluconazole and amphotericin B administered sequentially against Candida albicans:: Effect of concentration and exposure time [J].

Ernst, EJ ;

Klepser, ME ;

Pfaller, MA .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 32 (03) :205-210

[4] In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods [J].

Ernst, EJ ;

Klepser, ME ;

Ernst, ME ;

Messer, SA ;

Pfaller, MA .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 33 (02) :75-80

[5] Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida ssp. [J].

Ernst, ME ;

Klepser, ME ;

Wolfe, EJ ;

Pfaller, MA .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 26 (3-4) :125-131

[6] Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations [J].

Johnson, EM ;

Ojwang, JO ;

Szekely, A ;

Wallace, TL ;

Warnock, DW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (06) :1412-1416

[7] Evaluation of voriconazole pharmacodynamics using time-kill methodology [J].

Klepser, ME ;

Malone, D ;

Lewis, RE ;

Ernst, EJ ;

Pfaller, MA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1917-1920

[8] Influence of test conditions on antifungal time-kill curve results: Proposal for standardized methods [J].

Klepser, ME ;

Ernst, EJ ;

Lewis, RE ;

Ernst, ME ;

Pfaller, MA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) :1207-1212

[9] Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans [J].

Klepser, ME ;

Wolfe, EJ ;

Jones, RN ;

Nightingale, CH ;

Pfaller, MA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1392-1395

[10]

National Committee for Clinical Laboratory Standards, 1997, M27A NAT COMM CLIN L